Persistent Plus Disease Subsequent to Panretinal Photocoagulation in an Infant With Retinopathy of Prematurity

Copyright 2019, SLACK Incorporated.

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 50(2019), 8 vom: 01. Aug., Seite 520-521
1. Verfasser: Shah, Saumya M (VerfasserIn)
Weitere Verfasser: Callaway, Natalia F, Moshfeghi, Darius M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Journal Article
LEADER 01000naa a22002652 4500
001 NLM300259786
003 DE-627
005 20231225102127.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||eng c
024 7 |a 10.3928/23258160-20190806-08  |2 doi 
028 5 2 |a pubmed24n1000.xml 
035 |a (DE-627)NLM300259786 
035 |a (NLM)31415700 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Shah, Saumya M  |e verfasserin  |4 aut 
245 1 0 |a Persistent Plus Disease Subsequent to Panretinal Photocoagulation in an Infant With Retinopathy of Prematurity 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.01.2020 
500 |a Date Revised 01.01.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Copyright 2019, SLACK Incorporated. 
520 |a Plus disease, or the presence of vascular dilation and tortuosity, is the most reliable predictor of the progression of retinopathy of prematurity (ROP), making resolution of plus disease one of the earliest signs of ROP regression. Patients with certain comorbid conditions such as anemia and cardiovascular disease may have persistent plus-like disease following successful resolution of ROP. The authors present a case of a 24-week premature infant who was treated with panretinal photocoagulation for stage 3, zone II. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:520-521.] 
650 4 |a Journal Article 
700 1 |a Callaway, Natalia F  |e verfasserin  |4 aut 
700 1 |a Moshfeghi, Darius M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmic surgery, lasers & imaging retina  |d 2013  |g 50(2019), 8 vom: 01. Aug., Seite 520-521  |w (DE-627)NLM224956647  |x 2325-8179  |7 nnns 
773 1 8 |g volume:50  |g year:2019  |g number:8  |g day:01  |g month:08  |g pages:520-521 
856 4 0 |u http://dx.doi.org/10.3928/23258160-20190806-08  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_40 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_90 
912 |a GBV_ILN_91 
912 |a GBV_ILN_130 
912 |a GBV_ILN_135 
912 |a GBV_ILN_136 
912 |a GBV_ILN_151 
912 |a GBV_ILN_181 
912 |a GBV_ILN_203 
912 |a GBV_ILN_217 
912 |a GBV_ILN_235 
912 |a GBV_ILN_289 
912 |a GBV_ILN_294 
912 |a GBV_ILN_297 
912 |a GBV_ILN_350 
912 |a GBV_ILN_352 
912 |a GBV_ILN_674 
912 |a GBV_ILN_676 
912 |a GBV_ILN_688 
912 |a GBV_ILN_698 
912 |a GBV_ILN_721 
912 |a GBV_ILN_737 
912 |a GBV_ILN_791 
912 |a GBV_ILN_812 
951 |a AR 
952 |d 50  |j 2019  |e 8  |b 01  |c 08  |h 520-521